ReviewCalcified tissue international2026
Amelogenin Phosphorylation Affects Key Regulatory Genes in the Enamel Organ.
Review in Calcified tissue international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial "Enamel" Issue.Calcified tissue international · 2026Article
- Amelogenin Phosphorylation Affects Protein-Protein Interactions In Vivo.Calcified tissue international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Amelogenin (AMELX), the predominant enamel matrix protein (EMP), has a single phosphorylation site at Serine 16 (S16), which enhances its capacity to stabilize amorphous calcium phosphate and inhibit crystallization in vitro. To investigate the role of AMELX phosphorylation in vivo, we generated a knock-in (KI) mouse model, AmelxS16A, in which S16 is substituted with Alanine that prevents AMELX phosphorylation. KI enamel is hypoplastic, lacks the enamel rods, and features multiple ectopic calcifications. Notably, KI ameloblasts lack Tomes’ processes and develop progressive cell pathologies, suggesting that AMELX phosphorylation affects ameloblast biology. To gain a comprehensive view on the effects of AMELX phosphorylation on the biology of the enamel organ (EO) cells, we performed single-cell RNA sequencing on incisal EOs from WT and KI mice. Using this approach, we found that 624 genes were differentially expressed between WT and KI in total EO cell populations. In particular, genes encoding secretory stage EMPs were upregulated in KI mice, while genes encoding maturation-stage EMPs were downregulated. Ingenuity Pathway Analysis revealed that the pathways associated with cell morphology, growth, and proliferation are most affected in KI cells. Ten distinct cell populations of the EO were identified using cluster analysis. Additionally, our analyses showed that AMELX phosphorylation affects the expression of several genes involved in the regulation of odontogenesis. Furthermore, differentially expressed genes were concentrated in the secretory ameloblast (SA) cluster, suggesting that the SAs were most affected by the lack of AMELX phosphorylation. Specifically, there was a substantial 5.1-fold downregulation of Shh, while Wnt5a was upregulated 8.1-fold in KI SAs compared to WT. This dysregulation of regulatory genes may contribute to the observed ameloblast abnormalities in KI. In summary, our transcriptomics analysis reveals that AMELX phosphorylation not only affects numerous extracellular processes during amelogenesis but also influences multiple cellular pathways and processes within the EO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.